These findings are supported by a recent report using a TALE-dependent approach [15], in which promoter-specific demethylation caused a significant up-regulation of DPYSL3 gene/CRMP4 protein expression, leading to reduced cancer cell migration and tumor metastasis. This evidence concerns the gene DPYSL3 and neoplasm.